Husaiens, Collaboration for Business Expansion with Design by J

[Financial News] Husaiens, a clinical trial sample analysis affiliate of DT&C Bio Group, announced on the 11th that it has signed a strategic business agreement with Design by J to strengthen competitiveness in the domestic pharmaceutical and bio industry market.
Through this agreement, the two companies plan to organically combine their expertise in clinical trial sample analysis and verified business strategies and development capabilities. This aims to provide a foundation for offering precise and practical clinical research strategy solutions to companies pursuing new drug development.
Furthermore, they plan to jointly discover and expand a new clinical research service model that combines Husaiens' analysis platform with Design by J's strategic planning capabilities. Based on this, they intend to expand the cooperation network with domestic and international pharmaceutical and bio companies and accelerate entry into the global market.
Jo Kwon, CEO of Husaiens, stated, "As an advanced clinical trial sample analysis institution, we will add Design by J's business development capabilities to our clinical trial analysis capabilities through this agreement," and "We will strive to become a trusted partner that supports the growth of the industry by increasing the success potential of new drug development for domestic and international pharmaceutical and bio companies."
Jeong Bo-young, CEO of Design by J, said, "Husaiens is a highly potential institution based on an advanced clinical trial analysis platform and professional personnel," and "Through our strategic planning capabilities and business development (BD) consulting experience, we plan to actively support Husaiens in building and growing a more practical and sustainable business strategy as a GCLP institution."
Husaiens is a central laboratory (Central Lab) that provides services related to the entire cycle of clinical trial sample analysis, including not only experiments necessary for clinical trial sample analysis but also task management, logistics systems, experimental method verification, and development tailored to customer needs.
As the first clinical trial sample analysis institution in Korea, it obtained the 'ISO 17025' accredited testing institution qualification from the Korea Accreditation Board (KOLAS) and, in addition, was the first central lab in Korea to acquire certification from the College of American Pathologists (CAP), proving global-level analysis reliability and quality. It plans to further strengthen its competitiveness in global clinical trial sample analysis services by obtaining Clinical Laboratory Improvement Amendments (CLIA) certification in the future.
Design by J is a customized business strategy consulting company specialized in the bio-healthcare industry, conducting numerous license in-out, mergers and acquisitions (M&A), and overseas partnering projects for leading domestic and international companies. In particular, Jeong Bo-young, who is also active as the Chief Business Development Officer (CBO) at Preclinical, is recognized as a business development strategy expert in the domestic non-clinical CRO industry.

butter@fnnews.com Kang Kyung-rae Reporter